Contrasts EsoCheck’s powerful cell collection capabilities to “cruder, decades-old” technologies during comments on patient access to medical technology innovation NEW YORK, Feb. 15, 2024 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”) a commercial-stage,…